Polaryx Therapeutics, Inc. (PLYX) stock
PLYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.60−0.07 (-4.19%)
Close on Nov 17, 2026Market cap $79.75MP/E –Yield –
Polaryx Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Polaryx Therapeutics's enterprise value was $85.66M on Nov 11, 2026.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $85.66M | – |
See a number that looks wrong?